Skin Cancer/Precancer

LATEST NEWS

Tumor Thickness and Determining Pathological Risk, Prognosis in BCC

By

Brandon May

A relationship between tumor thickness and histopathological growth patterns in basal cell carcinoma (BCC) investigated.

Higher Rate of Treatment Discontinuation Seen in Real-World Patients With Melanoma

By

Jonathan Goodman, MPhil

Relapse-free survival outcomes were similar between real-world and clinical trial patients.

Vismodegib Demonstrates Efficacy in Basal Cell Carcinoma

By

Brandon May

Vismodegib treatment in local advanced and metastatic basal cell carcinoma is assessed.

FDA Takes New Action to Improve Quality, Efficacy of Sunscreens

As part of its ongoing implementation of new authorities for certain over-the-counter drugs, the FDA has taken actions aimed at improving the quality, safety, and efficacy of sunscreens.

Genomic Similarities in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Found

By

Estie Mermelstein, MSN, FNP-BC

The largest AK whole-exsome sequencing study to date is reported on.

Survival Up With Tebentafusp in Metastatic Uveal Melanoma

For patients with previously untreated metastatic uveal melanoma, treatment with tebentafusp results in longer overall survival than control therapy.

Adjuvant Pembrolizumab Prolongs Relapse-Free Survival in Stage II Melanoma

By

Andrea S. Blevins Primeau, PhD, MBA

Adjuvant pembrolizumab prolongs relapse-free survival, when compared with placebo, in patients with resected, stage II melanoma.

Oncolytic Therapy Adds No Survival Benefit to PD-1 Treated Advanced Melanoma

By

Mark L. Fuerst

Median OS was not reached for the T-VEC plus pembrolizumab arm and 49.2 months for the placebo plus pembrolizumab arm.

Pretreatment Found to Reduce Stages of Mohs Surgery for Basal Cell Carcinoma

By

Jennifer Larson

A retrospective study evaluated the effect of 5% imiquimod prior to Mohs surgery in patients with basal cell carcinoma.

Characterizing Patient-Reported Skin Reactions to 5-Fluorouracil in Actinic Keratosis

By

Emily Pond

The frequency and severity of skin reactions in patients with actinic keratosis is evaluated.